Refametinib | m-entrepreneurship.com

Product Name :
Refametinib

Search keywords :
Refametinib

drugId :
null

Target Vo:
Dual specificity mitogen-activated protein kinase kinase 2

Target Vo Short Name :
MEK2

Moa_Name:
Dual specificity mitogen-activated protein kinase kinase 1 inhibitors

First Approval Country :

First Approval Date Filter:
null

Origin Company_Name :
Valeant

Active Company_Name :

Active Indication_Name:

In Active Indication_Name:
Carcinoma, Hepatocellular

Termination Status :
Phase 2 Clinical

China Termination Status :
Phase 2 Clinical

Highest Status:
Pending

China Highest Status:
Pending

Antibodies are immunoglobulins secreted by effector lymphoid B cells into the bloodstream. Antibodies consist of two light peptide chains and two heavy peptide chains that are linked to each other by disulfide bonds to form a “Y” shaped structure. Both tips of the “Y” structure contain binding sites for a specific antigen. Antibodies are commonly used in medical research, pharmacological research, laboratory research, and health and epidemiological research. They play an important role in hot research areas such as targeted drug development, in vitro diagnostic assays, characterization of signaling pathways, detection of protein expression levels, and identification of candidate biomarkers.
Related websites: https://www.medchemexpress.com/antibodies.html
Popular product recommendations:
Cy7-conjugated AffiniPure Goat Anti-Mouse IgG H&L Purity & Documentation
Cleaved-Caspase 3 p12 Rabbit mAb Biological Activity
Lactate Dehydrogenase Antibody: Lactate Dehydrogenase Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 37 kDa, targeting to Lactate Dehydrogenase. It can be used for WB,ICC/IF,IHC-P,FC,IP assays with tag free, in the background of Human, Mouse.

Author: Betaine hydrochloride

Related Posts